Rosacea
Practical Pearls
Cosmeceuticals and Alternative Therapies for Rosacea
Rosacea is a skin condition mediated by a proinflammatory predisposition on the skin. A cosmeceutical approach supports the stable microbiome of...
Original Research
Lack of Significant Anti-inflammatory Activity With Clindamycin in the Treatment of Rosacea: Results of 2 Randomized, Vehicle-Controlled Trials
Rosacea is a chronic inflammatory skin disease of the face. The objective of the studies described here was to evaluate the efficacy of...
Cosmetic Corner
Cosmetic Corner: Dermatologists Weigh in on Redness-Reducing Products
Commentary
Rosacea Treatment Schema: An Update
When tasked with outlining updated therapy regimens for rosacea, specific patient vignettes come to mind. A 53-year-old male golfer presents with...
Feature
Dermatologist calls for paradigm shift on treating ocular rosacea
A new approach for treating ocular rosacea is on its way.
Conference Coverage
Topical tretinoin resolves inflammatory symptoms in rosacea, in small study
SYDNEY, AUSTRALIA – A small study found that topical tretinoin was useful and well tolerated for most of the patients with rosacea.
Conference Coverage
Some data support botulinum toxin for psoriasis and rosacea
ORLANDO – Can psoriasis and rosacea symptoms be significantly improved with neuromodulator treatment?
Conference Coverage
Acne, rosacea prescriptions cost more when prescribed by dermatologists
Dermatologists tend to prescribe pricier medicines than other physicians when treating acne and rosacea.
Conference Coverage
Rosacea research reveals advances, promising therapies
MIAMI - Management of rosacea continues to challenge dermatologists and patients alike, although new advances and recent studies shine a light on...
Original Research
Cost of Diagnosing Psoriasis and Rosacea for Dermatologists Versus Primary Care Physicians
Growing incentives to control health care costs may cause accountable care organizations (ACOs) to reconsider how skin disease is best managed...
Conference Coverage
VIDEO: Oxymetazoline approval expands options for rosacea
WAILEA, Hawaii The FDA’s approval of oxymetazoline 1% cream (Rofade) for the background erythema of rosacea is big news, says Linda Stein Gold, MD...